{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:09:34Z","timestamp":1772168974245,"version":"3.50.1"},"update-to":[{"DOI":"10.12688\/f1000research.73647.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000}},{"DOI":"10.12688\/f1000research.73647.2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000}}],"reference-count":28,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns5:p>\n                    <ns5:bold>Objective:<\/ns5:bold>\n                    Core outcome sets (COS) are an agreed standardised collection of outcomes created with representation from all key stakeholders (such as patients, clinicians, researchers), which should be reported as a minimum for all trials in that corresponding clinical area. There has been little research investigating the use of core outcomes in Health technology assessments (HTAs) and none in non-oncology HTAs. This study aimed to assess the similarity between COS and HTA outcomes.\n                  <\/ns5:p>\n                  <ns5:p>\n                    <ns5:bold>Methods:<\/ns5:bold>\n                    Ten COS published between 2015 and 2019 were selected, with patient participation taken as a proxy measure for a high quality COS. The INAHTA database was used as a source to identify relevant HTAs, which were accessed through the hyperlinks provided. Outcomes selected for these assessments were categorised as either a specific, partial or no match compared to the COS. An additional cohort of non-oncology HTAs published between 2019 and 2021 were identified from the NICE website and compared against a relevant COS.\n                  <\/ns5:p>\n                  <ns5:p>\n                    <ns5:bold>Results:<\/ns5:bold>\n                    Six hundred and fifty-one HTAs were matched to the ten COS areas, of which 119 were reviewed. Of a possible\n                    <ns5:bold\/>\n                    1318 core outcome matches, there were 562 (43%) matches, 413 (31%) specific and 149 (11%) partial. NICE HTA matches against corresponding COS ranged from 44% to 100%, with a total of 78% (73\/94) matches, 57 (61%) specific and 16 (17%) partial.\n                  <\/ns5:p>\n                  <ns5:p>\n                    <ns5:bold>Conclusion:<\/ns5:bold>\n                    Further work is required to promote the awareness and implementation of COS within HTAs. The degree of matching between COS and NICE HTA outcomes is encouraging, demonstrating acceptance of COS by HTA producers.\n                  <\/ns5:p>","DOI":"10.12688\/f1000research.73647.3","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T09:55:05Z","timestamp":1651571705000},"page":"1084","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A pilot study assessing the similarity between core outcome sets and outcomes included in health technology assessments"],"prefix":"10.12688","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0549-759X","authenticated-orcid":false,"given":"Peter","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"R. Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-3337","authenticated-orcid":false,"given":"Susanna","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"ref1","article-title":"Criteria for distinguishing effectiveness from efficacy trials in systematic reviews.","author":"G Gartlehner","year":"2006"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"972-9","DOI":"10.1001\/jamainternmed.2013.627","article-title":"Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials. gov.","volume":"173","author":"B Hirsch","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000007\/full","article-title":"The impact of cochrane reviews: The Cochrane Collaboration.","author":"D Tovey","year":"2010"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"226-9","DOI":"10.1093\/schbul\/sbr140","article-title":"Content and quality of 10 000 controlled trials in schizophrenia over 60 years.","volume":"39","author":"J Miyar","year":"2013","journal-title":"Schizophr. Bull."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"257-66","DOI":"10.1016\/S0140-6736(13)62296-5","article-title":"Increasing value and reducing waste: addressing inaccessible research.","volume":"383","author":"A Chan","year":"2014","journal-title":"Lancet."},{"key":"ref7","first-page":"163-6","article-title":"Core outcome sets. Archives of Disease in Childhood-Education and Practice.","volume":"103","author":"J Webbe","year":"2018"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1-8","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider.","volume":"13","author":"P Williamson","year":"2012","journal-title":"Trials."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e1002447","DOI":"10.1371\/journal.pmed.1002447","article-title":"Core outcome Set-STAndards for development: the COS-STAD recommendations.","volume":"14","author":"J Kirkham","year":"2017","journal-title":"PLoS Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12688\/hrbopenres.13139.2","article-title":"Representation of published core outcome sets for research in regulatory guidance: protocol.","volume":"4","author":"S Dodd","year":"2021","journal-title":"HRB Open Research."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"187-90","DOI":"10.1017\/S0266462320000215","article-title":"The new definition of health technology assessment: A milestone in international collaboration.","volume":"36","author":"B O'Rourke","year":"2020","journal-title":"Int. J. Technol. Assess. Health Care."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e00742","DOI":"10.1002\/prp2.742","article-title":"Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision-making of oncology medicines.","volume":"9","author":"R Kalf","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref13","article-title":"Health-related quality of life task and finish group report. Report 4: Core outcome sets 2020."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0222418","DOI":"10.1371\/journal.pone.0222418","article-title":"Assessing the impact of a research funder\u2019s recommendation to consider core outcome sets.","volume":"14","author":"K Hughes","year":"2019","journal-title":"PLoS One."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1-7","DOI":"10.1186\/s13063-020-04403-1","article-title":"Core outcome sets through the healthcare ecosystem: the case of type 2 diabetes mellitus.","volume":"21","author":"S Dodd","year":"2020","journal-title":"Trials."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"168-79","DOI":"10.1016\/j.jclinepi.2021.04.019","article-title":"More than half of systematic reviews have relevant core outcome sets.","volume":"136","author":"I Saldanha","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"476-9","DOI":"10.1136\/annrheumdis-2017-212256","article-title":"2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.","volume":"77","author":"H Radner","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1446-53","DOI":"10.1212\/WNL.0000000000002474","article-title":"Recommendations for observational studies of comorbidity in multiple sclerosis.","volume":"86","author":"R Marrie","year":"2016","journal-title":"Neurology."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e1002187","DOI":"10.1371\/journal.pmed.1002187","article-title":"A core outcome set for the benefits and adverse events of bariatric and metabolic surgery: the BARIACT project.","volume":"13","author":"K Coulman","year":"2016","journal-title":"PLoS Med."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"105-10","DOI":"10.1016\/j.yebeh.2016.01.036","article-title":"Which outcomes should we measure in adult epilepsy trials? The views of people with epilepsy and informal carers.","volume":"59","author":"A Noble","year":"2016","journal-title":"Epilepsy Behav."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1-8","DOI":"10.1186\/s13063-017-2364-y","article-title":"A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study.","volume":"18","author":"M Byrne","year":"2017","journal-title":"Trials."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1784-6","DOI":"10.1016\/j.jid.2017.04.017","article-title":"Identifying what to measure in acne clinical trials: first steps towards development of a core outcome set.","volume":"137","author":"A Layton","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e001767","DOI":"10.1161\/JAHA.115.001767","article-title":"Standardized outcome measurement for patients with coronary artery disease: consensus from the International Consortium for Health Outcomes Measurement (ICHOM).","volume":"4","author":"R McNamara","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"83-93","DOI":"10.1111\/1471-0528.15335","article-title":"Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study.","volume":"126","author":"S Meher","year":"2019","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1137-44","DOI":"10.1001\/jamadermatol.2018.1165","article-title":"Identifying a core domain set to assess psoriasis in clinical trials.","volume":"154","author":"K Duffin","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"677-85","DOI":"10.1001\/jamaoncol.2016.4851","article-title":"A standard set of value-based patient-centered outcomes for breast cancer: the international consortium for health outcomes measurement (ICHOM) initiative.","volume":"3","author":"W Ong","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"114-23","DOI":"10.1016\/j.jclinepi.2020.09.029","article-title":"A systematic review finds core outcome set uptake varies widely across different areas of health.","volume":"129","author":"K Hughes","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1768-75","DOI":"10.1093\/annonc\/mdw233","article-title":"Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries.","volume":"27","author":"S Kleijnen","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1-4","DOI":"10.1017\/S0266462319000825","article-title":"The \u2018top 10\u2019 challenges for health technology assessment: INAHTA viewpoint.","volume":"36","author":"B O'Rourke","year":"2020","journal-title":"Int. J. Technol. Assess. Health Care."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/10-1084\/v3\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/10-1084\/v3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/10-1084\/v3\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T05:10:13Z","timestamp":1651641013000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/10-1084\/v3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":28,"URL":"https:\/\/doi.org\/10.12688\/f1000research.73647.3","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.133578.r136562","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.133578.r136562","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/10-1084\/v3#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.121621.r125645, Catriona McDaid, York Trials Unit, Department of Health Sciences, University of York, York, UK, 04 Mar 2022, version 2, 1 approved, 1 approved with reservations","URL":"https:\/\/f1000research.com\/articles\/10-1084\/v2#referee-response-125645","order":0,"name":"referee-response-125645","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.133578.r136562, Alison E. Turnbull, Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA, 04 May 2022, version 3, indexed","URL":"https:\/\/f1000research.com\/articles\/10-1084\/v3#referee-response-136562","order":1,"name":"referee-response-136562","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}